Predictors of Outcome in t-PA Treated Stroke.

Completed

Phase N/A Results N/A

Summary of Purpose

Stroke is among the most disabilitating diseases worldwide in terms of numbers affected and its consequences. A relatively new and well documented treatment of acute ischemic stroke today is tPA (tissue plasminogen activator; will be called thrombolysis from now on) Unfortunately only a minority of patients is given this treatment. The large randomised controlled trials that investigated the safety and efficacy...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 December 2011.

1 Jan 2007 6 Jul 2011 1 Feb 2010 1 Feb 2010 1 Dec 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts

Not available